"Skin Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the SKIN.
Descriptor ID |
D012878
|
MeSH Number(s) |
C04.588.805 C17.800.882
|
Concept/Terms |
Skin Neoplasms- Skin Neoplasms
- Neoplasms, Skin
- Neoplasm, Skin
- Skin Neoplasm
Cancer of Skin- Cancer of Skin
- Skin Cancers
- Cancer of the Skin
- Skin Cancer
- Cancer, Skin
- Cancers, Skin
|
Below are MeSH descriptors whose meaning is more general than "Skin Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Skin Neoplasms".
This graph shows the total number of publications written about "Skin Neoplasms" by people in this website by year, and whether "Skin Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
1997 | 1 | 0 | 1 |
2000 | 1 | 0 | 1 |
2001 | 1 | 0 | 1 |
2002 | 1 | 0 | 1 |
2003 | 2 | 0 | 2 |
2004 | 1 | 0 | 1 |
2005 | 2 | 0 | 2 |
2006 | 4 | 1 | 5 |
2007 | 6 | 0 | 6 |
2008 | 2 | 0 | 2 |
2009 | 1 | 0 | 1 |
2010 | 2 | 0 | 2 |
2011 | 2 | 0 | 2 |
2012 | 5 | 1 | 6 |
2013 | 8 | 1 | 9 |
2014 | 5 | 0 | 5 |
2015 | 11 | 1 | 12 |
2016 | 20 | 2 | 22 |
2017 | 234 | 28 | 262 |
2018 | 194 | 18 | 212 |
2019 | 102 | 8 | 110 |
2020 | 26 | 3 | 29 |
2021 | 14 | 1 | 15 |
To return to the timeline, click here.
Below are the most recent publications written about "Skin Neoplasms" by people in Profiles.
-
Primary cutaneous anaplastic large-cell lymphoma with marked spontaneous regression of organ manifestation after SARS-CoV-2 vaccination. Br J Dermatol. 2021 12; 185(6):1259-1262.
-
Exploring the implications of the first COVID-19 lockdown on patients with melanoma: a national survey. Clin Exp Dermatol. 2022 Jan; 47(1):114-116.
-
Comment on "The impact of the COVID-19 pandemic on the presentation status of newly diagnosed melanoma: A single institution experience". J Am Acad Dermatol. 2021 12; 85(6):e419-e420.
-
Effects of COVID-19 Lockdown on Tumour Burden of Melanoma and Cutaneous Squamous Cell Carcinoma. Acta Derm Venereol. 2021 08 25; 101(8):adv00525.
-
Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program. Am J Clin Dermatol. 2021 Sep; 22(5):693-707.
-
The impact of the Covid-19 pandemic on quality of life in skin cancer patients. PLoS One. 2021; 16(8):e0255501.
-
The impact of the COVID-19 pandemic on diagnostic delay of skin cancer: a call to restart screening activities. J Eur Acad Dermatol Venereol. 2021 Dec; 35(12):e836-e837.
-
Hidden in plain sight: the (other) danger of COVID-19. Melanoma Res. 2021 08 01; 31(4):389-392.
-
Impact of the COVID-19 pandemic on melanoma diagnosis. J Eur Acad Dermatol Venereol. 2021 Nov; 35(11):e714-e715.
-
Effects of COVID-19 restriction measures and clinical resetting on delayed melanoma diagnosis: a single-institution experience. Ital J Dermatol Venerol. 2021 Aug; 156(4):497-498.